Furthermore, the mutation markedly reduced the synergistic activation between HAND2 and GATA4 as well as NKX2.5—the two other cardiac core transcription factors most commonly associated with CHD in humans (McCulley and Black 2012; Andersen et al. 2014). The gene discussed is NKX2-5; the disease is coronary artery disorder.